Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Compositions and methods for activating signaling through the CB1 cannabinoid receptor for treating and preventing diseases and disorders characterized by abnormal cellular accumulation of sphingolipids such as sphingomyelin

Compositions and methods for activating signaling through the CB1 cannabinoid receptor for treating and preventing diseases and disorders characterized by abnormal cellular accumulation of sphingolipids such as sphingomyelin

US Patent 12485117 · Granted Dec 2, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions and methods for activating signaling through the CB1 cannabinoid re2024
Compositions and methods for activating signaling through the CB1 cannabinoid re2024
Compositions and methods for activating signaling through the CB1 cannabinoid re2024
Therapeutic acid ceramidase compositions and methods of making and using them2021
Ceramidase and cell differentiation2019
Therapeutic acid ceramidase compositions and methods of making and using them2019
Dose escalation enzyme replacement therapy for treating acid sphingomyelinase de2019
Ceramide levels in the treatment and prevention of infections2018
Therapeutic acid ceramidase compositions and methods of making and using them2018
Targeted protein replacement for the treatment of lysosomal storage disorders2017
Dose escalation enzyme replacement therapy for treating acid sphingomyelinase de2017
Ceramide levels in the treatment and prevention of infections2016